Who owns FUSION PHARMACEUTICALS INC?
- Ticker: FUSN
- CUSIP Number: 36118a100
Tip: Access positions for across all investors
Analyze quarterly positions in Fusion Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Fusion Pharmaceuticals stock
Who bought or sold FUSION PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Federated Investors | 11M | $105M | 2% | Dec 2023 |
|
| Perceptive Advisors | 6.8M | $146M | 148% | Mar 2024 |
|
| Avidity Partners Management | 6.5M | $139M | 0% | Mar 2024 |
|
| Deerfield Management Company | 6.4M | $137M | 0% | Mar 2024 |
|
| Fil | 4.2M | $89M | 100% | Mar 2024 |
|
| Pentwater Capital Management | 3.8M | $81M | 100% | Mar 2024 |
|
| Johnson & Johnson | 3.7M | $78M | 0% | Mar 2024 |
|
| Millennium Management | 2.9M | $63M | 410% | Mar 2024 |
|
| Tpg Gp A | 2.6M | $54M | 0% | Mar 2024 |
|
| TIG Advisors | 1.9M | $41M | 100% | Mar 2024 |
|
| FMR | 1.8M | $39M | -56% | Mar 2024 |
|
| Marshall Wace | 1.5M | $32M | 371% | Mar 2024 |
|
| Verition Fund Management | 1.2M | $26M | 100% | Mar 2024 |
|
| Qube Research & Technologies | 987k | $21M | 100% | Mar 2024 |
|
| William Blair $ Company | 779k | $17M | -22% | Mar 2024 |
|
| Fort Baker Capital Management | 768k | $16M | 100% | Mar 2024 |
|
| Wellington Management Company | 745k | $7.2M | 100% | Dec 2023 |
|
| Walleye Trading Advisors | 657k | $14M | 162% | Mar 2024 |
|
| Citadel Advisors | 643k | $14M | 748% | Mar 2024 |
|
| Jane Street | 634k | $14M | 2153% | Mar 2024 |
|
| Jpmorgan Chase & Co | 606k | $13M | 4217% | Mar 2024 |
|
| Alpine Associates Management | 585k | $13M | 100% | Mar 2024 |
|
| Eagle Health Investments | 580k | $12M | 0% | Mar 2024 |
|
| BlackRock | 517k | $11M | 6162% | Mar 2024 |
|
| Balyasny Asset Management | 487k | $10M | 100% | Mar 2024 |
|
| Sphera Funds Management | 449k | $9.6M | -59% | Mar 2024 |
|
| Duquesne Family Office | 400k | $8.5M | 100% | Mar 2024 |
|
| Two Sigma Investments | 353k | $7.5M | 196% | Mar 2024 |
|
| Parallax Volatility Advisers | 347k | $7.4M | 100% | Mar 2024 |
|
| Susquehanna International | 303k | $6.5M | 100% | Mar 2024 |
|
| Morgan Stanley | 298k | $6.4M | 79% | Mar 2024 |
|
| Cowen And Company | 258k | $19k | 100% | Mar 2024 |
|
| Privium Fund Management B.V. | 251k | $5.4M | 77% | Mar 2024 |
|
| Sio Capital Management | 243k | $5.2M | -1% | Mar 2024 |
|
| Equitec Proprietary Markets | 241k | $5.1M | 100% | Mar 2024 |
|
| Atika Capital Management | 233k | $5.0M | 100% | Mar 2024 |
|
| Harvest Management | 230k | $4.9M | 100% | Mar 2024 |
|
| ADAR1 Capital Management | 177k | $3.8M | 100% | Mar 2024 |
|
| Brown Trout Management | 170k | $3.6M | 100% | Mar 2024 |
|
| Fred Alger Management | 167k | $3.6M | -46% | Mar 2024 |
|
| Hudson Bay Capital Management | 165k | $3.5M | 100% | Mar 2024 |
|
| Axa | 165k | $3.5M | 100% | Mar 2024 |
|
| Sofinnova Ventures | 157k | $3.4M | 34% | Mar 2024 |
|
| Maso Capital Partners | 150k | $3.2M | 100% | Mar 2024 |
|
| HealthInvest Partners AB | 139k | $3.0M | 11% | Mar 2024 |
|
| Centiva Capital | 110k | $2.3M | 100% | Mar 2024 |
|
| Vivaldi Asset Management | 108k | $2.3M | 100% | Mar 2024 |
|
| Springbok Capital Management | 103k | $2.2M | 100% | Mar 2024 |
|
| ClearAlpha Technologies | 102k | $2.2M | 100% | Mar 2024 |
|
| Omni Event Management | 100k | $2.1M | 100% | Mar 2024 |
|
| Natixis | 99k | $2.1M | 100% | Mar 2024 |
|
| Jump Financial | 86k | $828k | 100% | Dec 2023 |
|
| CNH Partners | 86k | $1.8M | 100% | Mar 2024 |
|
| Swiss National Bank | 86k | $1.8M | 100% | Mar 2024 |
|
| Tudor Investment Corporation | 85k | $1.8M | 100% | Mar 2024 |
|
| UBS Group | 80k | $1.7M | -64% | Mar 2024 |
|
| Yarbrough Capital | 77k | $1.6M | 0% | Mar 2024 |
|
| Gts Securities | 72k | $1.5M | 100% | Mar 2024 |
|
| Bank of America Corporation | 72k | $1.5M | 5115% | Mar 2024 |
|
| Glazer Capital | 67k | $1.4M | 100% | Mar 2024 |
|
| American Century Companies | 57k | $1.2M | 100% | Mar 2024 |
|
| Cubist Systematic Strategies | 56k | $1.2M | -17% | Mar 2024 |
|
| Maven Securities | 53k | $1.1M | 100% | Mar 2024 |
|
| Wexford Capital | 50k | $1.1M | 100% | Mar 2024 |
|
| Caption Management | 48k | $1.0M | 100% | Mar 2024 |
|
| Goldman Sachs Group | 47k | $1.0M | 212% | Mar 2024 |
|
| Geode Capital Management | 42k | $894k | 36% | Mar 2024 |
|
| Belvedere Trading | 41k | $878k | 100% | Mar 2024 |
|
| CSS | 41k | $876k | 100% | Mar 2024 |
|
| Fifth Lane Capital | 41k | $874k | 100% | Mar 2024 |
|
| Credit Suisse | 41k | $873k | 100% | Mar 2024 |
|
| California State Teachers Retirement System | 39k | $832k | 100% | Mar 2024 |
|
| Legal & General Group | 38k | $812k | 100% | Mar 2024 |
|
| Raymond James Financial Services Advisors | 36k | $769k | 16% | Mar 2024 |
|
| Vanguard Group | 33k | $704k | 100% | Mar 2024 |
|
| State of Wisconsin Investment Board | 32k | $684k | 100% | Mar 2024 |
|
| Ing Investment Management | 30k | $646k | 100% | Mar 2024 |
|
| Yakira Capital Management | 30k | $644k | 100% | Mar 2024 |
|
| Citigroup | 25k | $539k | 1829% | Mar 2024 |
|
| JBF Capital | 25k | $533k | 100% | Mar 2024 |
|
| Mint Tower Capital Management B.V. | 25k | $533k | 100% | Mar 2024 |
|
| NEOS Investment Management | 19k | $400k | 7% | Mar 2024 |
|
| Hrt Financial | 18k | $381k | 100% | Mar 2024 |
|
| ProShare Advisors | 18k | $376k | 100% | Mar 2024 |
|
| Beryl Capital Management | 16k | $345k | 100% | Mar 2024 |
|
| Titleist Asset Management | 16k | $342k | 100% | Mar 2024 |
|
| Northern Trust | 14k | $298k | 100% | Mar 2024 |
|
| China Universal Asset Management | 14k | $297k | 66% | Mar 2024 |
|
| Arizona State Retirement System | 12k | $255k | 100% | Mar 2024 |
|
| Two Sigma Advisers | 12k | $249k | 2% | Mar 2024 |
|
| Crystalline Management | 11k | $239k | 100% | Mar 2024 |
|
| Cutler | 10k | $213k | 400% | Mar 2024 |
|
| Greenland Capital Management | 10k | $213k | 100% | Mar 2024 |
|
| Bluefin Capital Management | 10k | $213k | 100% | Mar 2024 |
|
| Teacher Retirement System Of Texas | 9.7k | $206k | 100% | Mar 2024 |
|
| Barclays | 8.7k | $185k | 100% | Mar 2024 |
|
| Zurcher Kantonalbank | 5.3k | $112k | 100% | Mar 2024 |
|
| Signature | 2.9k | $63k | 0% | Mar 2024 |
|
| Wells Fargo & Company | 1.5k | $32k | -70% | Mar 2024 |
|
| Royal Bank of Canada | 924.00 | $20k | -97% | Mar 2024 |
|
| TD Waterhouse Canada | 700.00 | $15k | 0% | Mar 2024 |
|
| Tower Research Capital | 508.00 | $11k | 265% | Mar 2024 |
|
| Toth Financial Advisory Corporation | 501.00 | $11k | 100% | Mar 2024 |
|
| Daiwa Securities Group | 268.00 | $6.0k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 86.00 | $1.8k | 0% | Mar 2024 |
|
| FNY Investment Advisers | 85.00 | $999.999500 | 100% | Mar 2024 |
|
| GAMMA Investing | 26.00 | $554.000200 | 100% | Mar 2024 |
|
| Scarborough Advisors | 13.00 | $277.000100 | 100% | Mar 2024 |
|
Who sold out of Fusion Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| OrbiMed Advisors | Dec 2023 | 3.1M | $30M |
| Artal Group | Dec 2023 | 1.0M | $9.7M |
| Ikarian Capital | Dec 2023 | 500k | $4.8M |
| Jennison Associates | Dec 2023 | 301k | $2.9M |
| Point72 Asset Management | Dec 2023 | 294k | $2.8M |
| Pier Capital | Dec 2023 | 277k | $2.7M |
| Weiss Multi-strategy Advisers | Dec 2023 | 172k | $1.7M |
| Schonfeld Strategic Advisors | Dec 2023 | 154k | $1.5M |
| Woodline Partners | Sep 2023 | 78k | $203k |
| Raymond James & Associates | Dec 2023 | 52k | $497k |
| Chartwell Investment Partners | Dec 2023 | 50k | $480k |
| Superstring Capital Management | Dec 2023 | 46k | $440k |
| Forefront Analytics | Sep 2023 | 34k | $88k |
| Standard Life Aberdeen | Dec 2023 | 22k | $209k |
| Squarepoint Ops | Dec 2023 | 13k | $123k |
| Simplex Trading | Dec 2023 | 13k | $120k |
| New York State Common Retirement Fund | Dec 2023 | 6.6k | $64k |
| Dorsey Wright & Associates | Sep 2023 | 878.00 | $2.3k |
| National Bank Of Canada /fi/ | Sep 2023 | 500.00 | $1.2k |